Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Revolution Medicines Inc (NASDAQ: RVMD) was $36.48 for the day, up 0.88% from the previous closing price of $36.16. In other words, the price has increased by $0.88 from its previous closing price. On the day, 1.96 million shares were traded. RVMD stock price reached its highest trading level at $36.54 during the session, while it also had its lowest trading level at $35.42.
Ratios:
Our analysis of RVMD’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 11.79 and its Current Ratio is at 11.79. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on August 19, 2025, initiated with a Overweight rating and assigned the stock a target price of $75.
On August 15, 2025, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $67.
On July 15, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $65.Goldman initiated its Buy rating on July 15, 2025, with a $65 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 20 ’25 when Cislini Jeff sold 1,912 shares for $39.61 per share. The transaction valued at 75,736 led to the insider holds 54,093 shares of the business.
JEFFREY TODD CISLINI bought 1,912 shares of RVMD for $76,346 on Jun 20 ’25. On Jun 16 ’25, another insider, Horn Margaret A, who serves as the Chief Operating Officer of the company, sold 3,510 shares for $39.83 each. As a result, the insider received 139,803 and left with 150,675 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVMD now has a Market Capitalization of 6819315712 and an Enterprise Value of 4814938624.
Stock Price History:
The Beta on a monthly basis for RVMD is 1.12, which has changed by -0.16406965 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, RVMD has reached a high of $62.40, while it has fallen to a 52-week low of $29.17. The 50-Day Moving Average of the stock is -3.15%, while the 200-Day Moving Average is calculated to be -12.10%.
Shares Statistics:
RVMD traded an average of 2.25M shares per day over the past three months and 2163380 shares per day over the past ten days. A total of 186.90M shares are outstanding, with a floating share count of 162.01M. Insiders hold about 13.33% of the company’s shares, while institutions hold 91.90% stake in the company. Shares short for RVMD as of 1753920000 were 13930629 with a Short Ratio of 6.18, compared to 1751241600 on 16101450. Therefore, it implies a Short% of Shares Outstanding of 13930629 and a Short% of Float of 7.93.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The performance of Revolution Medicines Inc (RVMD) in the stock market is under the watchful eye of 11.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$1.5, with high estimates of -$1.2 and low estimates of -$1.73.
Analysts are recommending an EPS of between -$4.69 and -$5.6 for the fiscal current year, implying an average EPS of -$5.28. EPS for the following year is -$5.76, with 12.0 analysts recommending between -$4.47 and -$7.69.
